Abstract:Tasuku Yamamoto, 1, 2 Keiji Oishi, 1 Syuichiro Ohata, 1 Yoriyuki Murata, 1 Yoshikazu Yamaji, 1 Maki Asami-Noyama, 1 Nobutaka Edakuni, 1 Tomoyuki Kakugawa, 3 Tsunahiko Hirano, 1 Kazuto Matsunaga 1 1 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan; 2 Department of Respiratory Medicine, National Hospital Organization Yamaguchi-Ube Medical Center, Ube, Yamaguchi, Japan; 3 Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan Correspondence: Keiji Oishi, Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan, Tel +81 836 85 3123, Fax +81 836 85 3124, Email Background: Reports from Europe and North America suggest that female chronic obstructive pulmonary disease (COPD) patients have a higher symptom burden and mortality than male patients. However, little is known about the management reality of female patients with COPD in Japan. Patients and Methods: We compared the clinical characteristics of female COPD patients with those of male using the cohort of the COPD Assessment in Practice study, which is a cross-sectional multicenter observational study. Results: Of the 1168 patients, 133 (11.4%) were female. A history of never smoking was higher in females than males (p< 0.01). Although there was no difference in age or forced expiratory volume in one second (FEV 1 ) % predicted between the groups, modified medical research council dyspnea scale (mMRC) and number of frequent exacerbators were higher in females (mMRC≥ 2: p< 0.01; number of exacerbations≥ 2: p=0.011). The mean forced vital capacity and FEV 1 values in females were lower than those in males (p< 0.0001 and p< 0.0001, respectively). Females were more likely to use long-term oxygen therapy and inhaled corticosteroids than males (p=0.016 and p< 0.01, respectively). The prevalence of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups B, C, D (ABCD GOLD 2017 classification), and E (ABE GOLD 2023 classification) was higher in females than in males. Conclusion: The disease burden of female patients with COPD is higher than that of male patients in Japan, suggesting the importance of interventions considering female-dominant features such as lower absolute FVC and FEV 1 , respiratory failure, and asthma-like conditions. Keywords: chronic obstructive pulmonary disease, exacerbation, subjective symptoms, gender difference, observational study Epidemiological studies in Europe and the United States have reported that women with chronic obstructive pulmonary disease (COPD) have an increased mortality rate 1,2 and a higher symptom burden than men. 3,4 Additionally, it has become evident that females possess clinically noteworthy characteristics distinct from males in terms of etiology, exacerbating factors such as exposure to causative agents, anatomical and physiological factors, comorbidities. These characteristics are believed to be associated with the heightened symptom awareness observed in females. Smoking is a major cause of COPD regardless of gender; however, in females, the smoking rate is relatively low, 1,5–7 while they are significantly influenced by factors such as air pollution, the use of biomass fuels for household chores, and exposure to secondhand smoke. 8,9 According to reports from Spain, occupational exposure is associated with COPD risk, 10 and differences in occupations between males and females may influence variations in the etiology of COPD. Report from Korea indicates that in females, there is a higher prevalence of COPD comorbidity among patients with lower household income and education levels, suggesting that the high smoking rates in these demographics, as well as a higher prevalence of smoking from a younger age, may be contributing factors. 7 It may be related to the fact that while the smoking rate is decreasing among men, reflecting factors such as increased female participation in society during the past several decades, the smoking rate among women is not declining, which may be contributing to the lack of decrease in mortality rates. COPD related to biomass combustion is a significant public health issue, particularly in developing countries where women are predominantly responsible for household chores. It has been reported that particular matter 2.5 (PM2.5), a major air pollutant, significantly reduces the transition from alveol -Abstract Truncated-

Relationship between gender and survival in a real-life cohort of patients with COPD

[Effects of gender on pulmonary rehabilitation outcomes in patients with COPD]

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

Women and COPD: do we need more evidence?

Gender does not impact the short- or long-term outcomes of home-based pulmonary rehabilitation in patients with COPD

Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: a Prospective 18-Month Follow-Up Study

Cognition on the diagnosis and treatment of COPD patients in different genders

Lung Cancer in Women—Sociodemographic, Clinical and Psychological Characteristics with Comparison to Men

Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan

High-risk patients following hospitalisation for an acute exacerbation of COPD

Gender Differences in the Diagnosis of Chronic Obstructive Pulmonary Disease after Spirometry

Sex-differences in COPD: from biological mechanisms to therapeutic considerations

Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD

Impact of the COVID-19 Pandemic on COPD Patient Mortality: A Nationwide Study in France

Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR)

Diagnosis and treatment considerations for women with COPD

Gender Difference on the Knowledge, Attitude, and Practice of COPD Diagnosis and Treatment: a National, Multicenter, Cross-Sectional Survey in China.

Factors affecting the relationship between psychological status and quality of life in COPD patients

Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype

Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES